Thrombosis and Haemostasis

Papers
(The H4-Index of Thrombosis and Haemostasis is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban311
Discontinuation of anticoagulants and occurrence of bleeding and thromboembolic events in vitamin K antagonist users with a life-limiting disease281
Binding Promiscuity of Therapeutic Factor VIII85
Utility of Sepsis-induced Coagulopathy among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study73
67
Anticoagulant Treatment of COVID-19 as Early as Possible—Sulodexide and Perspectives52
Inhibition of IP3 (Inositol 1,4,5-Trisphosphate) Receptors Retards SARS-CoV-2-Induced Endothelial von Willebrand Factor Secretion and Thrombosis51
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial47
Hyperhomocysteinemia in Cardiovascular Diseases: Revisiting Observational Studies and Clinical Trials43
Factor VIIa–Antithrombin Complexes are Increased in Asthma: Relation to the Exacerbation-Prone Asthma Phenotype40
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel40
Clinical and Genetic Characterization of 51 Patients with Congenital Fibrinogen Disorders from China38
Of Mice and Man: The Unwinding of CLEC-2 as an Antithrombotic Target?35
Does Fibrinolytic Strategy of Pulmonary Embolism International THrOmbolysis (PEITHO)-3 Trial Need More Strong Evidence?35
34
33
Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials32
Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke32
Heparin and Direct Oral Anticoagulants have Different Effects on the Phases of Activation and Spatial Spread of Blood Coagulation32
DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation31
MicroRNAs as Biomarkers for Personalized Antiplatelet Therapy30
Thrombosis and Haemostasis 2024 Editors' Choice Papers29
Significant Major Bleeding in Hospitalized Patients with COVID-19 Receiving Thromboprophylaxis29
Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis29
Newborn and Pediatric Reference Intervals for Coagulation Assays Using Novel Reagents28
Roles of ROCK/Myosin Pathway in Macrothrombocytopenia in Bernard–Soulier Syndrome28
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites27
Tyrosine Kinase Inhibitor Sunitinib Delays Platelet-Induced Coagulation: Additive Effects of Aspirin27
Relationship Between Screening-Detected Atrial Fibrillation and Blood Pressure Levels in Elderly Hypertensive Patients: The OMRON Heart Study27
A Systematic Review of Anticoagulation Strategies for Patients with Atrial Fibrillation in Critical Care27
0.13689398765564